This archive contains the following articles listed by volume, issue and page number:
 |
|
|
| HAZARDOUS DRUGS RELATED ARTICLES |
| Title (Click for Details) |
Vol/Issue |
Page |
| Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets |
Vol. 24 No. 1 |
7 |
| Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk |
Vol. 24 No. 1 |
21 |
| Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs |
Vol. 24 No. 1 |
30 |
| Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators |
Vol. 23 No. 6 |
447 |
| Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control |
Vol. 23 No. 6 |
511 |
| Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report |
Vol. 23 No. 5 |
358 |
| Contamination Control in Compounding Areas |
Vol. 23 No. 4 |
271 |
| How to Develop and Maintain a Hazardous Drug List |
Vol. 23 No. 3 |
182 |
| Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? |
Vol. 23 No. 2 |
123 |
| Certification of Powder-containment Hoods for Nonsterile Compounding |
Vol. 22 No. 5 |
369 |
| Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations |
Vol. 22 No. 5 |
387 |
| Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags |
Vol. 22 No. 4 |
345 |
| Trace Level Analysis of Airborne Hormone Particulates |
Vol. 22 No. 3 |
257 |
| PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs |
Vol. 21 No. 5 |
356 |
| PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives |
Vol. 21 No. 3 |
180 |
| Quality Control: (Material) Safety Data Sheets |
Vol. 21 No. 2 |
118 |
| Bosentan 6.25-mg/mL Oral Suspension |
Vol. 20 No. 6 |
505 |
| Erlotinib 10-mg/mL Oral Suspension |
Vol. 20 No. 6 |
508 |
| Imatinib 40-mg/mL Oral Suspension |
Vol. 20 No. 6 |
510 |
| PreScription: Patient Access to Pharmaceuticals |
Vol. 20 No. 3 |
180 |
| Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) |
Vol. 20 No. 2 |
148 |
| Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom |
Vol. 19 No. 4 |
268 |
| Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety |
Vol. 18 No. 3 |
222 |
| A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards |
Vol. 18 No. 2 |
94 |
| Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety |
Vol. 17 No. 6 |
485 |
| Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists |
Vol. 17 No. 3 |
182 |
| Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum |
Vol. 16 No. 2 |
117 |
| Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting |
Vol. 13 No. 4 |
300 |
| Compounding for Cancer in Companion Animals |
Vol. 13 No. 1 |
42 |
| Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs |
Vol. 13 No. 1 |
56 |
| Disposing of Expired Drugs and Chemicals: New Options for Compounders |
Vol. 12 No. 1 |
38 |
| PostScription: Consumer Options for Disposal of Unused Medications |
Vol. 12 No. 1 |
87 |
| Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations |
Vol. 11 No. 2 |
149 |
| Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection |
Vol. 11 No. 1 |
50 |
| Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination |
Vol. 10 No. 6 |
446 |
| Basics of Compounding for Hazardous Drugs, Part 1: An Introduction |
Vol. 10 No. 5 |
377 |
| Standard Operating Procedure: Labconco Basic 47 Laboratory Hood |
Vol. 10 No. 2 |
135 |
| Local Ventilation for Safe Containment in the Pharmaceutical Industry |
Vol. 9 No. 4 |
293 |
| Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products |
Vol. 9 No. 4 |
284 |
| Using ACDs in the Practice of Pharmacy |
Vol. 9 No. 1 |
15 |
| An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices |
Vol. 7 No. 5 |
401 |
| Containment of Hazardous Particulates in the Compounding Pharmacy |
Vol. 7 No. 4 |
281 |
| Product Containment in the Compounding Laboratory |
Vol. 7 No. 3 |
213 |
| Facilities and Procedures for Compounding Hazardous Drugs |
Vol. 6 No. 4 |
267 |
| Compounding Containment Devices: Buyer Be Aware |
Vol. 5 No. 5 |
384 |
| Sterile Compounding with Barrier-Isolation Technology |
Vol. 5 No. 4 |
254 |
| Compounding Using Hazardous Drugs |
Vol. 4 No. 4 |
261 |
